News Feed

Jan 4, 2018

New Drug Abuse Potential assessment service

Scitegrity launches new Drug Abuse Potential assessment service

Scitegrity is pleased to announcement the launch of its new Drug Abuse Potential Assessment service.

Scitegrity director Joe Bradley on launching the service said “in early 2017 the FDA produced new guidance relating to drug abuse assessment for NDA submissions which included the chemical assessment of the submitted compound to all existing scheduled 1 to 5 substances or drug legislation, including chemical space descriptions and derivatives such as ethers, esters etc. This is quite a difficult assessment to do accurately and quickly if you do not already have access to the required data sets, algorithms or tools. Given Scitegritys intimate knowledge of controlled drug laws we are able to rapidly produce these reports for our clients”.

For more information please see our section on Drug Abuse Potential

Bookmark and Share